Clinical research progress of budesonide in the treatment of bronchial asthma
Bronchial asthma is a relatively common clinical disease,after the onset of the disease,the patient's airway exhibits a variable inflammatory response,which belongs to chronic respiratory diseases,its main symptoms are repeated wheezing,cough,accompanied by dyspnea,hypoxia,chest tightness,etc.,which has a greater harm to the health and safety of patients.In recent years,under the action of many factors,the incidence of bronchial asthma has increased significantly.Related studies have shown that inhaled corticosteroids can effectively control patients'clinical symptoms,relieve patients'physical discomfort and promote patients'physical recovery,which has good therapeutic effect.At present,there are many glucocorticoid drugs in the clinical treatment of bronchial asthma,among which methylprednisolone,dexamethasone,prednisone and budesonide are the most widely used.Budesonide has good clinical effect in the treatment of bronchial asthma and has many clinical applications.This paper analyzes the harm of bronchial asthma disease,and explores the clinical effect of budesonide in the treatment of bronchial asthma and its influence on patients by summarizing the literature related to the treatment of bronchial asthma with budesonide,so as to provide guidance for the clinical treatment of bronchial asthma.
万方数据
维普
